Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
Turkey (Türkiye)
Ankara T.C. Ministry of Health, Ankara, Turkey Istanbul Universitesi faculty of Medicine, Istanbul, Turkey